United States · FDA National Drug Code directory
VARIVAX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-4827_482dc109-86b1-405e-89fa-6a4c5e04c756
- Product NDC
- 0006-4827
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Composition / generic term
- Varicella Virus Vaccine Live
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 19950317
- Source listing expiry
- 20271231
Source-listed ingredients
- VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN — 1350 [PFU]/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4827-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4827-01) · 0006-4827-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →